vTv Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new
orally administered treatments for Alzheimer’s disease and diabetes, today announced that Company management will present a
corporate overview at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Wednesday, July 13, 2016 at 8:00 a.m. ET in New York
City.
A live webcast of the presentation can be accessed on the News & Events section of the website. The webcast will be archived for 30 days following the presentation on
the company website at www.vtvtherapeutics.com.
About vTv Therapeutics
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally
administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates
led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the
prevention of muscle weakness.
Investors
The Trout Group
Michael Gibralter, 646-378- 2938
mgibralter@troutgroup.com
or
Media
BMC Communications
Brad Miles, 646-513- 3125
bmiles@bmccommunications.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160706005257/en/